Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Deficit - USD ($) shares in Thousands, $ in Thousands	Total	Previously Reported	Reverse recapitalization	Common Stock	Common Stock Previously Reported	Common Stock Reverse recapitalization	Additional Paid-In Capital	Additional Paid-In Capital Previously Reported	Additional Paid-In Capital Reverse recapitalization	Accumulated Deficit	Accumulated Deficit Previously Reported	Accumulated Deficit Reverse recapitalization	Accumulated Comprehensive Income (Loss)	Accumulated Comprehensive Income (Loss) Previously Reported	Accumulated Comprehensive Income (Loss) Reverse recapitalization
Beginning balance (in shares) at Dec. 31, 2024	62,240	93,963	(31,723)
Beginning balance at Dec. 31, 2024	$ 170,648	$ 170,648	$ 0
Ending balance (in shares) at Mar. 31, 2025	62,240
Ending balance at Mar. 31, 2025	$ 170,648
Beginning balance (in shares) at Dec. 31, 2024				58,057	87,646	(29,589)
Beginning balance at Dec. 31, 2024	(250,835)	$ (250,835)	$ 0	$ 6	$ 0	$ 6	$ 17,303	$ 17,309	$ (6)	$ (268,144)	$ (268,144)	$ 0	$ 0	$ 0	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of common stock warrants (in shares)				17
Issuance of common stock upon exercise of stock options (in shares)				942
Issuance of common stock upon exercise of stock options	508						508
Stock-based compensation	1,878						1,878
Net income (loss)	(128,185)									(128,185)
Ending balance (in shares) at Mar. 31, 2025				59,016
Ending balance at Mar. 31, 2025	$ (376,634)			$ 6			19,689			(396,329)			0
Beginning balance (in shares) at Dec. 31, 2024	62,240	93,963	(31,723)
Beginning balance at Dec. 31, 2024	$ 170,648	$ 170,648	$ 0
Ending balance (in shares) at Jun. 30, 2025	62,240
Ending balance at Jun. 30, 2025	$ 170,648
Beginning balance (in shares) at Dec. 31, 2024				58,057	87,646	(29,589)
Beginning balance at Dec. 31, 2024	(250,835)	$ (250,835)	$ 0	$ 6	$ 0	$ 6	17,303	$ 17,309	$ (6)	(268,144)	$ (268,144)	$ 0	0	$ 0	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(241,911)
Ending balance (in shares) at Jun. 30, 2025				59,742
Ending balance at Jun. 30, 2025	$ (486,919)			$ 6			23,130			(510,055)			0
Beginning balance (in shares) at Mar. 31, 2025	62,240
Beginning balance at Mar. 31, 2025	$ 170,648
Ending balance (in shares) at Jun. 30, 2025	62,240
Ending balance at Jun. 30, 2025	$ 170,648
Beginning balance (in shares) at Mar. 31, 2025				59,016
Beginning balance at Mar. 31, 2025	(376,634)			$ 6			19,689			(396,329)			0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				726
Issuance of common stock upon exercise of stock options	428						428
Stock-based compensation	3,013						3,013
Net income (loss)	(113,726)									(113,726)
Ending balance (in shares) at Jun. 30, 2025				59,742
Ending balance at Jun. 30, 2025	$ (486,919)			$ 6			23,130			(510,055)			0
Ending balance (in shares) at Sep. 24, 2025	174,957
Beginning balance (in shares) at Dec. 31, 2025	142
Beginning balance at Dec. 31, 2025	$ 223,185
Ending balance (in shares) at Mar. 31, 2026	142
Ending balance at Mar. 31, 2026	$ 223,185
Beginning balance (in shares) at Dec. 31, 2025	175,440			175,440
Beginning balance at Dec. 31, 2025	$ (283,052)			$ 17			570,578			(853,669)			22
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of common stock warrants (in shares)				386
Issuance of common stock upon exercise of common stock warrants	3,584						3,584
Issuance of common stock upon exercise of stock options (in shares)				1,650
Issuance of common stock upon exercise of stock options	973			$ 1			972
Stock-based compensation	6,111						6,111
Other comprehensive loss	(24)												(24)
Net income (loss)	26,490									26,490
Ending balance (in shares) at Mar. 31, 2026				177,476
Ending balance at Mar. 31, 2026	$ (245,918)			$ 18			581,245			(827,179)			(2)
Beginning balance (in shares) at Dec. 31, 2025	142
Beginning balance at Dec. 31, 2025	$ 223,185
Ending balance (in shares) at Jun. 30, 2026	142
Ending balance at Jun. 30, 2026	$ 223,185
Beginning balance (in shares) at Dec. 31, 2025	175,440			175,440
Beginning balance at Dec. 31, 2025	$ (283,052)			$ 17			570,578			(853,669)			22
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	2,368
Net income (loss)	$ 38,967
Ending balance (in shares) at Jun. 30, 2026	194,173			194,173
Ending balance at Jun. 30, 2026	$ (188,918)			$ 19			625,883			(814,702)			(118)
Beginning balance (in shares) at Mar. 31, 2026	142
Beginning balance at Mar. 31, 2026	$ 223,185
Ending balance (in shares) at Jun. 30, 2026	142
Ending balance at Jun. 30, 2026	$ 223,185
Beginning balance (in shares) at Mar. 31, 2026				177,476
Beginning balance at Mar. 31, 2026	(245,918)			$ 18			581,245			(827,179)			(2)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of common stock warrants (in shares)				594
Issuance of common stock upon exercise of common stock warrants	3,563						3,563
Issuance of common stock and warrants in connection with a private placement, net of transaction costs (in shares)				15,385
Issuance of common stock and warrants in connection with a private placement, net of transaction costs	34,126			$ 1			34,125
Issuance of common stock upon exercise of stock options (in shares)				718
Issuance of common stock upon exercise of stock options	469						469
Stock-based compensation	6,481						6,481
Other comprehensive loss	(116)												(116)
Net income (loss)	$ 12,477									12,477
Ending balance (in shares) at Jun. 30, 2026	194,173			194,173
Ending balance at Jun. 30, 2026	$ (188,918)			$ 19			$ 625,883			$ (814,702)			$ (118)